458 related articles for article (PubMed ID: 15912783)
1. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
Takizawa A; Miura T; Fujinami K; Osada Y
Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Rick O; Bokemeyer C; Weinknecht S; Schirren J; Pottek T; Hartmann JT; Braun T; Rachud B; Weissbach L; Hartmann M; Siegert W; Beyer J
J Clin Oncol; 2004 Sep; 22(18):3713-9. PubMed ID: 15365067
[TBL] [Abstract][Full Text] [Related]
4. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
5. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
6. Primary chemotherapy for stage 2 testis cancer.
Abratt RP; McAdam GL; Pontin AR; Barnes RD; Ball HS
S Afr J Surg; 1997 Nov; 35(4):203-5; discussion 205-6. PubMed ID: 9540399
[TBL] [Abstract][Full Text] [Related]
7. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours.
Napier MP; Naraghi A; Christmas TJ; Rustin GJ
Br J Cancer; 2000 Nov; 83(10):1274-80. PubMed ID: 11044349
[TBL] [Abstract][Full Text] [Related]
9. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on poor-risk patients with non-seminomatous germ cell tumor].
Okamura K; Takashi M; Hibi H; Tsuji Y; Shimoji T; Ohshima S; Takagi Y; Suzuki Y; Mizutani K; Ono Y; Kato T; Kobayashi M
Hinyokika Kiyo; 1998 Apr; 44(4):265-72. PubMed ID: 9617623
[TBL] [Abstract][Full Text] [Related]
11. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
Takasaki N; Ueda H; Isurugi K
Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
[TBL] [Abstract][Full Text] [Related]
12. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party.
Stenning SP; Parkinson MC; Fisher C; Mead GM; Cook PA; Fossa SD; Horwich A; Jones WG; Newlands ES; Oliver RT; Stenwig AE; Wilkinson PM
Cancer; 1998 Oct; 83(7):1409-19. PubMed ID: 9762943
[TBL] [Abstract][Full Text] [Related]
13. [Results of treatment for germ cell tumor--dose intensity of chemotherapy and residual masses after chemotherapy].
Matsuzaki J; Miyoshi Y; Miura T
Hinyokika Kiyo; 2000 Dec; 46(12):879-86. PubMed ID: 11211804
[TBL] [Abstract][Full Text] [Related]
14. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours.
Horvath LG; McCaughan BC; Stockle M; Boyer MJ
Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847
[TBL] [Abstract][Full Text] [Related]
15. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis.
Besse B; Grunenwald D; Fléchon A; Caty A; Chevreau C; Culine S; Théodore C; Fizazi K
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):448-52. PubMed ID: 19185168
[TBL] [Abstract][Full Text] [Related]
16. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
[TBL] [Abstract][Full Text] [Related]
17. [Management of advanced seminoma: retrospective study of 96 patients].
Bompas E; Fléchon A; Biron P; Droz JP
Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
[TBL] [Abstract][Full Text] [Related]
18. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
[TBL] [Abstract][Full Text] [Related]
19. Arterial thrombosis after cisplatin-based chemotherapy for metastatic germ cell tumors.
Cheng E; Berthold DR; Moore MJ; Duran I
Acta Oncol; 2009; 48(3):475-7. PubMed ID: 18932096
[No Abstract] [Full Text] [Related]
20. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
Albers P; Weissbach L; Krege S; Kliesch S; Hartmann M; Heidenreich A; Walz P; Kuczyk M; Fimmers R;
J Urol; 2004 May; 171(5):1835-8. PubMed ID: 15076288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]